Suppr超能文献

常染色体显性遗传性 Best 病和常染色体隐性致病变异的 BEST1 蛋白稳定性和降解途径不同,这解释了不同的视网膜表型。

BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes.

机构信息

Institute of Human Genetics, University of Regensburg, 93053 Regensburg, Germany.

Department of Psychiatry and Psychotherapy, Molecular Neurosciences, University of Regensburg, 93053 Regensburg, Germany.

出版信息

Hum Mol Genet. 2018 May 1;27(9):1630-1641. doi: 10.1093/hmg/ddy070.

Abstract

Mutations in bestrophin-1 (BEST1) are associated with distinct retinopathies, notably three forms with autosomal dominant inheritance and one condition with an autosomal recessive mode of transmission. The molecular mechanisms underlying their distinct retinal phenotypes are mostly unknown. Although heterozygous missense mutations in BEST1 reveal dominant-negative effects in patients with autosomal dominant Best disease (BD), heterozygous mutations associated with autosomal recessive bestrophinopathy (ARB) display no disease phenotype. Here we show that the recessive mutations trigger a strong and fast protein degradation process in the endoplasmic reticulum (ER), thereby favoring a decreased stoichiometry of mutant versus normal BEST1 subunits in the assembly of the homo-pentameric BEST1 chloride channel. In contrast, dominant mutations escape ER-associated degradation and are subjected to a slightly delayed post-ER degradation via the endo-lysosomal degradation pathway. As a result, increased formation of a non-functional BEST1 channel occurs due to a roughly equimolar incorporation of normal and mutant BEST1 subunits into the channel complex. Taken together, our data provide insight into the molecular pathways of dominantly and recessively acting BEST1 missense mutations suggesting that the site of subcellular protein quality control as well as the rate and degree of mutant protein degradation are ultimately responsible for the distinct retinal disease phenotypes in BD and ARB.

摘要

贝斯特素-1(BEST1)基因突变与不同的视网膜病变有关,特别是三种常染色体显性遗传形式和一种常染色体隐性遗传形式。其不同的视网膜表型的分子机制大多尚不清楚。虽然 BEST1 中的杂合错义突变在常染色体显性贝斯特病(BD)患者中显示出显性负效应,但与常染色体隐性贝斯特素病(ARB)相关的杂合突变则没有表现出疾病表型。在这里,我们发现隐性突变会在内质网(ER)中引发强烈和快速的蛋白降解过程,从而有利于在同型五聚体 BEST1 氯离子通道的组装中,突变体与正常 BEST1 亚基的比例降低。相比之下,显性突变逃避了 ER 相关降解,并通过内体溶酶体降解途径经历稍微延迟的 ER 后降解。结果,由于正常和突变 BEST1 亚基大致等量掺入通道复合物中,形成了无功能的 BEST1 通道,从而导致其形成增加。总的来说,我们的数据提供了对显性和隐性作用的 BEST1 错义突变的分子途径的深入了解,表明细胞内蛋白质质量控制的部位以及突变蛋白降解的速度和程度最终决定了 BD 和 ARB 中不同的视网膜疾病表型。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验